相关实验视频

Updated: Jun 11, 2025

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

新的Bis-1,2,3-triazole-thiazolidinone混合物作为诱导亡的抗癌剂和分子建模研究

Abdoullah Bimoussa¹, Ali Oubella², Manal A Alossaimi³

¹Laboratory of Organic Synthesis & Physico-Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Université Cadi Ayyad, BP PO Box 2390, Marrakech, 40001, Morocco.

Future medicinal chemistry

|October 10, 2024

概括

合成的 (R) - 卡基混合物通过诱导亡,表现出强大的抗癌活性. 这些化合物有效抑制与NIMA相关的激酶 (NEK),这表明癌症治疗的治疗潜力.

科学领域:

药用化学医学化学
有机合成有机合成
计算化学计算化学

背景情况:

癌症仍然是全球死亡的主要原因,需要新的治疗策略.
开发具有特定作用机制的有效抗癌剂至关重要.

研究的目的:

为了合成和表征基于 (R) 卡的新型1,2,3-三醇-硫二丁杂交物.
评估这些合成化合物对各种癌症细胞系的抗癌潜力.
阐明作用机制,包括亡诱导和酶抑制.

主要方法:

合成和光谱表征 (NMR,HRMS) 的化合物17a-h.
密度功能理论 (DFT) 用于化学反应性和稳定性分析.
在体外抗癌活性查针对癌症细胞系.
分子对接和分子动力学模拟以调查与酶向的相互作用.

主要成果:

化合物17b和17g显示出显著的抗癌活性.
有证据表明,通过17b和17g的caspase-3/7激活来诱导亡.
接研究确定这些化合物是NIMA相关激酶 (NEKs) 的强有力的抑制剂.
来自分子动力学的结合能量支持了对NEK家族的抑制潜力.

结论:

合成的 (R) 碳基混合物表现出有希望的抗癌特性.
该机制涉及诱导亡和抑制NEK家族激酶的机制.
这些发现突出了这些化合物的治疗潜力,用于治疗癌症.

关键词:

比斯-1,2,3-三醇是一种灭症 (apoptosis) 是一种死亡的过程.铜 (II) -催化铜 (II) -催化铜 (II) -催化铜 (II) -催化铜在体外具有细胞毒性.分子对接的分子对接.分子动力学分子动力学

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...